Congestive Heart Failure Pipeline Highlights - 2017 - Research and Markets

Research and Markets has announced the addition of the "Congestive Heart Failure Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Congestive Heart Failure Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Congestive Heart Failure market. It covers emerging therapies for Congestive Heart Failure in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Congestive Heart Failure pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Congestive Heart Failure pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Congestive Heart Failure pipeline products by the company.

Short-term Launch Highlights:

Find out which Congestive Heart Failure pipeline products will be launched in the US and Ex-US till 2020.

Summary:

• Congestive Heart Failure phase 3 clinical trial pipeline products
• Congestive Heart Failure phase 2 clinical trial pipeline products
• Congestive Heart Failure phase 1 clinical trial pipeline products
• Congestive Heart Failure preclinical research pipeline products
• Congestive Heart Failure discovery stage pipeline products
• Congestive Heart Failure pipeline products short-term launch highlights
  

Key Topics Covered:

1. Congestive Heart Failure Pipeline by Stages

2. Congestive Heart Failure Pipeline by Drug Class

3. Congestive Heart Failure Pipeline by Company

4. Congestive Heart Failure Phase 3 Clinical Trial Insights

5. Congestive Heart Failure Phase 2 Clinical Trial Insights

6. Congestive Heart Failure Phase 1 Clinical Trial Insights

7. Congestive Heart Failure Preclinical Research Insights

8. Congestive Heart Failure Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/87w72h/congestive_heart

View source version on businesswire.com: http://www.businesswire.com/news/home/20170120005148/en/